Yvette Bren‐Mattison

602 total citations
15 papers, 497 citations indexed

About

Yvette Bren‐Mattison is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yvette Bren‐Mattison has authored 15 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Yvette Bren‐Mattison's work include Neuroendocrine Tumor Research Advances (4 papers), Food Allergy and Anaphylaxis Research (3 papers) and Contact Dermatitis and Allergies (3 papers). Yvette Bren‐Mattison is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Food Allergy and Anaphylaxis Research (3 papers) and Contact Dermatitis and Allergies (3 papers). Yvette Bren‐Mattison collaborates with scholars based in United States, Brazil and Canada. Yvette Bren‐Mattison's co-authors include Robert A. Winn, Raphael A. Nemenoff, Bradley B. Olwin, Vicki Van Putten, Daniel C. Chan, Mark W. Geraci, Lynn E. Heasley, Melissa Hausburg, Nicholas P. Barry and Terence J. Van Raay and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Yvette Bren‐Mattison

13 papers receiving 492 citations

Peers

Countries citing papers authored by Yvette Bren‐Mattison

Since Specialization

Citations

This map shows the geographic impact of Yvette Bren‐Mattison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvette Bren‐Mattison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvette Bren‐Mattison more than expected).

Fields of papers citing papers by Yvette Bren‐Mattison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvette Bren‐Mattison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvette Bren‐Mattison. The network helps show where Yvette Bren‐Mattison may publish in the future.

Co-authorship network of co-authors of Yvette Bren‐Mattison

This figure shows the co-authorship network connecting the top 25 collaborators of Yvette Bren‐Mattison. A scholar is included among the top collaborators of Yvette Bren‐Mattison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvette Bren‐Mattison. Yvette Bren‐Mattison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers 2024 ·Journal of Cancer Research and Clinical Oncology ·Tao Xu, Joseph S. Dillon, Mary A. Maluccio, Dawn E. Quelle, Sarah H. Nash, (unknown), (unknown), Nicholas J. Skill, Yvette Bren‐Mattison, (unknown)	0
2	Adjuvant therapy for lung neuroendocrine neoplasms 2021 ·World Journal of Clinical Oncology ·Robert A. Ramirez, Katharine Thomas, Aasems Jacob, Karen Lin, Yvette Bren‐Mattison, Aman Chauhan	8
3	Detection of pancreatic cancer by convolutional-neural-network-assisted spontaneous Raman spectroscopy with critical feature visualization 2021 ·Neural Networks ·Zhongqiang Li, (unknown), Qing Chen, (unknown), Jian Zhang, J. Philip Boudreaux, Ramcharan Thiagarajan, Yvette Bren‐Mattison, Michael E. Dunham, Andrew J. McWhorter, Xin Li, Ji‐Ming Feng, Yanping Li, Shaomian Yao, Jian Xu	63
4	Characterization of Anti-Ana o 3 Monoclonal Antibodies and Their Application in Comparing Brazilian Cashew Cultivars 2021 ·Antibodies ·Christopher P. Mattison, (unknown), Ana Cecília Ribeiro de Castro, Heidi J. Chial, Yvette Bren‐Mattison, Peter J. Bechtel, Edy Sousa de Brito	1
5	A Neuroendocrine Tumor Specialty Center in New Orleans’ (NOLANETS) Response to Patient Care During the COVID-19 Pandemic 2020 ·The Oncologist ·Robert A. Ramirez, Yvette Bren‐Mattison, Ramcharan Thiagarajan, (unknown), (unknown), (unknown), Mary A. Maluccio	3
6	Neuroendocrine Tumors of the Ampulla of Vater Treated With Local Resection 2020 ·The American Surgeon ·George M. Jeha, J. Philip Boudreaux, Eugene A. Woltering, Yvette Bren‐Mattison, Ramcharan Thiagarajan	0
7	A cashew specific monoclonal antibody recognizing the small subunit of Ana o 3 2019 ·Toxicology Reports ·Christopher P. Mattison, (unknown), Yvette Bren‐Mattison, Casey C. Grimm	4
8	Cross-reaction between Formosan termite (Coptotermes formosanus) proteins and cockroach allergens 2017 ·PLoS ONE ·Christopher P. Mattison, Taruna Khurana, Matthew R. Tarver, Christopher B. Florane, Casey C. Grimm, Suman Pakala, (unknown), Claudia Riegel, Yvette Bren‐Mattison, Jay E. Slater	12
9	Identification and Characterization of Ana o 3 Modifications on Arginine-111 Residue in Heated Cashew Nuts 2016 ·Journal of Agricultural and Food Chemistry ·Christopher P. Mattison, Casey C. Grimm, Yi‐Chen Li, Heidi J. Chial, Darrell R. McCaslin, Si‐Yin Chung, Yvette Bren‐Mattison, Richard L. Wasserman	15
10	Heat-induced alterations in cashew allergen solubility and IgE binding 2016 ·Toxicology Reports ·Christopher P. Mattison, Yvette Bren‐Mattison, (unknown), (unknown), Richard L. Wasserman, Casey C. Grimm	34
11	Growth of limb muscle is dependent on skeletal-derived Indian hedgehog 2011 ·Developmental Biology ·Yvette Bren‐Mattison, Melissa Hausburg, Bradley B. Olwin	32
12	Antitumorigenic Effects of Peroxisome Proliferator-Activated Receptor-γ in Non-Small-Cell Lung Cancer Cells Are Mediated by Suppression of Cyclooxygenase-2 via Inhibition of Nuclear Factor-κB 2007 ·Molecular Pharmacology ·Yvette Bren‐Mattison, Amy M. Meyer, Vicki Van Putten, Howard Li, Katherine Kuhn, Robert S. Stearman, Mary C.M. Weiser‐Evans, Robert A. Winn, Lynn E. Heasley, Raphael A. Nemenoff	47
13	Restoration of Wnt-7a Expression Reverses Non-small Cell Lung Cancer Cellular Transformation through Frizzled-9-mediated Growth Inhibition and Promotion of Cell Differentiation 2005 ·Journal of Biological Chemistry ·Robert A. Winn, Lindsay A. Marek, Sun‐Young Han, Karen J. Rodriguez, (unknown), (unknown), Michelle Van Scoyk, (unknown), (unknown), Nicholas P. Barry, Yvette Bren‐Mattison, Terence J. Van Raay, Raphael A. Nemenoff, Lynn E. Heasley	140
14	Peroxisome proliferator-activated receptor-γ (PPARγ) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC) 2004 ·Oncogene ·Yvette Bren‐Mattison, Vicki Van Putten, Daniel C. Chan, Robert A. Winn, Mark W. Geraci, Raphael A. Nemenoff	105
15	Sonic Hedgehog Inhibits the Terminal Differentiation of Limb Myoblasts Committed to the Slow Muscle Lineage 2002 ·Developmental Biology ·Yvette Bren‐Mattison, Bradley B. Olwin	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact